Posts
July 26 2012
Infinity Cross Border AcquisitionCorporation (Nasdaq: INXBU) announced the closing of their SPAC IPO in the amount of $40,000,000. EG&S acted as counsel to Infinity.
July 20 2012
Saul H. Finkelstein, a member of the Firm, participated in a webinar on M&A Confidentiality Agreements. The panel reviewed the latest developments with non-disclosure agreements, examined key elements of the agreement, and offered negotiation approaches for sellers and buyers.
July 20 2012
Brianstorm Cell Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $972,500. EG&S acted as counsel to the placement agent.
July 19 2012
Douglas S. Ellenoff, a member of the Firm, participated in “The Crowdfund Act – Framing the new regulatory landscape Symposium” sponsored in Washington by the Crowdfund Intermediary Regulatory Advocates (CFIRA). Mr. Ellenoff spoke on two different panels: The Mechanics of a Crowdfund Offering and Reaching the Crowd.
July 19 2012
Assured Pharmacy, Inc. announced the closing of their Private Placement offering in the amount of $300,000. EG&S acted as counsel to the Investor.
July 19 2012
IsoRay, Inc. announced the closing of their Registered Direct offering in the amount of $3,500,000. EG&S acted as counsel to the placement agent.
July 06 2012
MYOS Corporation announced the closing of their PIPE offering in the amount of $5,600,000. EG&S acted as counsel to MYOS Corporation.
July 02 2012
Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for the first half of 2012.